Literature DB >> 6428177

Molecular aspects of immunoglobulin expression by human B cell leukemias and lymphomas.

J Gordon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6428177     DOI： 10.1016/s0065-230x(08)60015-9

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  6 in total

1.  Direct effect of interleukin 2 on chronic lymphocytic leukaemia B cell functions and morphology.

Authors:  V Malkovska; J Murphy; L Hudson; D Bevan
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

2.  Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemia.

Authors:  S Karfa; R Gopal; J S Nadkarni
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Development of plasmacytoid cells with Russell bodies in autoimmune "viable motheaten" mice.

Authors:  L D Shultz; D R Coman; B L Lyons; C L Sidman; S Taylor
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

4.  Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).

Authors:  E Kimby; B Axelsson; M Björkholm; J Gordon; G Holm; H Mellstedt
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

Review 5.  Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

Authors:  K Guy; A S Krajewski; A E Dewar
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

6.  Immunoglobulin negative follicle centre cell lymphoma.

Authors:  E O Gregg; N Al-Saffar; D B Jones; D H Wright; F K Stevenson; J L Smith
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.